US Patent

US11896562 — Oral amphetamine composition

Method of Use · Assigned to Adare Pharmaceuticals Inc · Expires 2037-03-10 · 11y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects oral pharmaceutical compositions, including taste-masked and orally disintegrating compositions, that contain amphetamine sulfate.

USPTO Abstract

In various embodiments, the present invention is directed to oral pharmaceutical compositions. For example, in some embodiments, the present invention is directed to taste-masked compositions. In some embodiments, the taste masked compositions comprise a highly water soluble drug such as amphetamine, e.g., in the form of a salt such as amphetamine sulfate. In various embodiments, the present invention is directed to taste-masked, orally disintegrating compositions.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-3299 — Amphetamine Sulfate
U-3299 — Amphetamine Sulfate
U-3299 — Amphetamine Sulfate
U-3299 — Amphetamine Sulfate

Patent Metadata

Patent number
US11896562
Jurisdiction
US
Classification
Method of Use
Expires
2037-03-10
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.